Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Agriterra ( (GB:PACS) ) has shared an announcement.
PACSCo Limited has outlined its financial reporting timetable, stating that its delayed 2025 annual accounts and 2026 unaudited interim accounts, for the periods ending 31 March 2025 and 30 September 2025 respectively, are expected to be finalised and published during January 2026, a step that should allow the company to apply for the lifting of the current suspension of trading in its ordinary shares on AIM. Separately, the company has secured approval from the Mozambique Competition Regulatory Authority for the disposal of its Mozambique Agricultural Businesses and is now working with the Bank of Mozambique to obtain remaining regulatory clearance, marking progress in its planned exit from these assets and potentially reshaping its operational footprint in the region.
Spark’s Take on GB:PACS Stock
According to Spark, TipRanks’ AI Analyst, GB:PACS is a Neutral.
Agriterra’s stock is currently facing significant challenges. The primary issues are financial performance marked by declining revenues and high leverage, which are compounded by weak technical indicators showing bearish trends. The valuation is also unfavorable due to negative earnings and lack of dividends, making it less appealing to investors. Improvement in operational efficiency and financial health is needed to boost investor confidence.
To see Spark’s full report on GB:PACS stock, click here.
More about Agriterra
PACSCo Limited is an AIM-listed company with agricultural operations in Mozambique, where it has owned Mozambique Agricultural Businesses that are now in the process of being disposed of, reflecting a strategic shift in its asset base.
Average Trading Volume: 568,798
Technical Sentiment Signal: Strong Sell
Current Market Cap: £323.2K
For detailed information about PACS stock, go to TipRanks’ Stock Analysis page.

